- Home
- PRTA vs ATRO Comparison
PRTA vs ATRO Comparison
Compare PRTA & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ATRO
- Stock Information
- Founded
- PRTA 2012
- ATRO 1968
- Country
- PRTA Ireland
- ATRO United States
- Employees
- PRTA N/A
- ATRO N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ATRO Military/Government/Technical
- Sector
- PRTA Health Care
- ATRO Industrials
- Exchange
- PRTA Nasdaq
- ATRO Nasdaq
- Market Cap
- PRTA 809.8M
- ATRO 844.1M
- IPO Year
- PRTA N/A
- ATRO N/A
- Fundamental
- Price
- PRTA $7.18
- ATRO $30.17
- Analyst Decision
- PRTA Buy
- ATRO Hold
- Analyst Count
- PRTA 9
- ATRO 1
- Target Price
- PRTA $51.71
- ATRO $21.00
- AVG Volume (30 Days)
- PRTA 1.6M
- ATRO 515.2K
- Earning Date
- PRTA 05-08-2025
- ATRO 05-06-2025
- Dividend Yield
- PRTA N/A
- ATRO N/A
- EPS Growth
- PRTA N/A
- ATRO N/A
- EPS
- PRTA N/A
- ATRO N/A
- Revenue
- PRTA $137,935,000.00
- ATRO $816,288,000.00
- Revenue This Year
- PRTA N/A
- ATRO $7.69
- Revenue Next Year
- PRTA $122.59
- ATRO $6.12
- P/E Ratio
- PRTA N/A
- ATRO N/A
- Revenue Growth
- PRTA 54.55
- ATRO 13.73
- 52 Week Low
- PRTA $8.00
- ATRO $14.13
- 52 Week High
- PRTA $25.42
- ATRO $26.63
- Technical
- Relative Strength Index (RSI)
- PRTA 30.36
- ATRO 76.15
- Support Level
- PRTA $6.47
- ATRO $23.25
- Resistance Level
- PRTA $8.08
- ATRO $30.31
- Average True Range (ATR)
- PRTA 0.72
- ATRO 1.07
- MACD
- PRTA 0.00
- ATRO 0.71
- Stochastic Oscillator
- PRTA 21.60
- ATRO 98.32
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.